DUBLIN--(BUSINESS WIRE)--The "Respiratory Disposables Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global respiratory disposables market was valued at about $1.4 billion in 2018 and is expected to grow to $1.49 billion at a CAGR of 1.5% through 2022.
The respiratory disposables market consists of sales of respiratory disposables and related services. Respiratory disposobles include disposable resuscitators, disposable masks, disposible tubes, and other consumables and accessories.
High prevalence rate of respiratory diseases globally is driving the respiratory disposables market. Excessive smoking, exposure to toxic materials, adverse climate conditions and air pollution are some of the main causes which are leading to rise in respiratory diseases such as asthma, lung cancer, Chronic Obstructive Pulmonary Disease (COPD) and obstructive sleep apnea (OSA). According to a study, around 65 million people suffer from chronic obstructive pulmonary disease (COPD) and around 3 million people die every year because of this disease. It was also reported that around 334 million people suffer from asthma diseases caused by air pollution as well as tobacco smoke, toxic disposable devices. These factors are increasing the demand for treatment of respiratory ailments, thus driving the respiratory diseases market.
Respiratory disposables market is being restrained due to stringent regulatory policies. Regulatory agencies and governments across various countries are imposing stringent restrictions on product approval and launch, this is limiting the market growth. For instance, in 2005, FDA banned Amphastar Pharmaceutical's Primatene product, an albuterol CFC inhalers for asthma because of ozone-depleting chlorofluorocarbon (CFC) propellants have depleted the ozone layer. In 2014, the FDA rejected Amphastar's first attempt to bring a reformulated version of Primatene mist to market. Again in 2016, the FDA rejected another application for Primatene Mist. In November 2018, FDA approved new formulation of Primatene Mist. Stringent regulations result in rise in development costs and potential sales loss due to delays in product launch, thus restraining the Respiratory disposables market.
Rapid advances in technology are driving innovation in respiratory disposable manufacturing. Areas of particular development are likely to be AIR gel technology, wearable technologies, and 3D printing technology. These technologies are being used in the manufacturing of respiratory disposables, resulting in higher productivity, lower costs and higher margins.
Companies in this market are increasingly focusing on AIR gel technology, in which gel is incorporated into the bag on the edges of the mask which helps to the protection of the skin and creates a bridge to minimize the irritation of the skin and for effective sealing. For example, Vyair medical prepared Veraseal 2 disposable mask, used for acute care with AIR gel technology and advantage of vented and non-vented versions. Similarly, Sleepnet prepared Mojo ventilation masks with Airgel technology.
In the USA, occupational safety and health administration (OSHA) regulates all respiratory medical equipment, guidelines for which are specified in 29 CFR 1910. 134. Under OSHA, national institute for occupational safety and health/national personal protective technology laboratory (NIOSH/ NPPTL) provides market approval certificate and FDA approves the product for marketing. Before market approval, all the medical devices should be analyzed appropriately by performing compatibility test within a hospital environment,. They are tested on Electrical bench and Non clinical performance testing is also required. Moreover, proper software verification, validation, and hazard analysis must be performed. Labels on the devices are required to include the purpose of the device.
In April 2018, Vyaire Medical acquired Acutronic Medical for an undisclosed amount. The acquisition is expected to enhance Vyaire's product portfolio, technological capabilities and expand their intellectual capital. Acutronic Medical develops and sells ventilation solutions for NICU's/PICU's, ICU's and Intensive Care Transportation. The company was founded in 1981 and is headquartered in Switzerland.
Major players in the market are Fisher & Paykel, Becton Dickinson Company, Ambu A/S, Smiths Medical, Armstrong Medical
- Markets Covered: 1) By Type: Masks, Tubes, Inhalers, Others 2) By End User: Hospitals, Clinics, Ambulatory Care Centers, Others 3) By Disease Indications: Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases 4) By Application: Adult, Pediatric & Neonatal
- Companies Mentioned: Fisher & Paykel, Becton Dickinson Company, Ambu A/S, Smiths Medical, Armstrong Medical
- Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
- Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
- Time Series: Five years historic and forecast.
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Other Companies Mentioned
- Philips Respironics
- Drive Medical
- Cardinal Health
- Drger Medical
- Hamilton Medical
- Mercury Medical
- Ningbo Greetmed Medical Instruments
- Hangzhou Jinlin Medical Appliances
- Hangzhou Tappa Medical Technology
- Ningbo Boya Medical Equipment
- Weihai Strong Medical Sci-Tech
- Vyaire Medical
- Flexicare Medical
For more information about this report visit https://www.researchandmarkets.com/r/2nfbr0